NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Trofinetide successful in Phase 2 trial in Fragile X, page-51

  1. 2,364 Posts.
    lightbulb Created with Sketch. 2092
    Roy .There will be a melbourne cup field from all around the world looking at neuren now .I spoke to the company awhile ago and they said that the tipping point for many large biotech centric/pharma companies investors would be after successful fragile x results .The next couple of days should be very interesting !!!!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.